These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7671349)

  • 1. Hypertrophic cardiomyopathy. Clinical spectrum and treatment.
    Wigle ED; Rakowski H; Kimball BP; Williams WG
    Circulation; 1995 Oct; 92(7):1680-92. PubMed ID: 7671349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy.
    Louie EK; Edwards LC
    Prog Cardiovasc Dis; 1994; 36(4):275-308. PubMed ID: 7904358
    [No Abstract]   [Full Text] [Related]  

  • 3. Symptomatic hypertrophic obstructive cardiomyopathy: the role of dual-chamber pacing.
    Park MH; Gilligan DM; Bernardo NL; Topaz O
    Angiology; 1999 Feb; 50(2):87-94. PubMed ID: 10063938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypertrophic cardiomyopathy in children.
    Seggewiss H; Rigopoulos A
    Paediatr Drugs; 2003; 5(10):663-72. PubMed ID: 14510624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug therapy of hypertrophic cardiomyopathy].
    Hartmann A; Kaltenbach M; Hopf R
    Fortschr Med; 1992 Sep; 110(27):485-8. PubMed ID: 1358773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertrophic cardiomyopathy (clinical aspects, diagnosis and treatment)].
    Paleev NR; Gurevich MA; Odinokova VA; Iankovskaia MO; Smirnov VB
    Kardiologiia; 1990 Nov; 30(11):7-13. PubMed ID: 1982327
    [No Abstract]   [Full Text] [Related]  

  • 7. Paroxysmal atrial fibrillation as a cause of potentially lethal ventricular arrhythmia with myocardial ischemia in hypertrophic cardiomyopathy--a case report.
    Suzuki M; Hirayama T; Marumoto K; Okayama H; Iwata T
    Angiology; 1998 Aug; 49(8):653-7. PubMed ID: 9717897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different beta-adrenergic regulation of myocardial contraction and relaxation between apical and nonobstructive hypertrophic cardiomyopathy.
    Zuo P; Izawa H; Ishiki R; Noda A; Nishizawa T; Shigemura K; Nagata K; Iwase M; Yokota M
    Am Heart J; 2000 Aug; 140(2):329-37. PubMed ID: 10925351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heart failure associated with hypertrophic cardiomyopathy].
    Oka N; Ohmura H; Ueda T
    Nihon Rinsho; 2007 May; 65 Suppl 5():425-9. PubMed ID: 17569322
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the prevalence, clinical features, and long-term outcomes of midventricular hypertrophy vs apical phenotype in patients with hypertrophic cardiomyopathy.
    Cai C; Duan FJ; Yang YJ; Guo XY; Liu YL; Liu YQ; Yan LR; Xu ZM; Zhao SH; Hua W; Li YS; Fan CM
    Can J Cardiol; 2014 Apr; 30(4):441-7. PubMed ID: 24468417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertrophic cardiomyopathy].
    Friart A
    Rev Med Brux; 1995; 16(4):182-4. PubMed ID: 7481219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy.
    Lu DY; Hailesealassie B; Ventoulis I; Liu H; Liang HY; Nowbar A; Pozios I; Canepa M; Cresswell K; Luo HC; Abraham MR; Abraham TP
    Int J Cardiol; 2017 Sep; 243():290-295. PubMed ID: 28747034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of hypertropic obstructive cardiomyopathy].
    Gleichmann U; Seggewiss H
    Dtsch Med Wochenschr; 1996 Nov; 121(48):1485-6. PubMed ID: 8983903
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical characteristics of rapid atrial fibrillation preceding ventricular tachycardia.
    Konagai H; Nitta J; Niwa A; Satoh Y; Nogami A; Aonuma K; Lesaka Y; Hiroe M; Marumo F
    Jpn Circ J; 2001 Dec; 65(12):1022-8. PubMed ID: 11767992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
    Link MS; Bockstall K; Weinstock J; Alsheikh-Ali AA; Semsarian C; Estes NAM; Spirito P; Haas TS; Rowin EJ; Maron MS; Maron BJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):531-537. PubMed ID: 28240435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy.
    Gilligan DM; Missouris CG; Boyd MJ; Oakley CM
    Am J Cardiol; 1991 Oct; 68(9):971-3. PubMed ID: 1927963
    [No Abstract]   [Full Text] [Related]  

  • 17. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical practice. Hypertrophic obstructive cardiomyopathy.
    Nishimura RA; Holmes DR
    N Engl J Med; 2004 Mar; 350(13):1320-7. PubMed ID: 15044643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hypertensive hypertrophic cardiomyopathy in older patients].
    Schuster P; Sturm A
    Dtsch Med Wochenschr; 1985 Nov; 110(44):1714-5. PubMed ID: 2865119
    [No Abstract]   [Full Text] [Related]  

  • 20. Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy.
    López Gil M; Arribas F; Cosío FG
    Europace; 2000 Oct; 2(4):327-32. PubMed ID: 11194600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.